A major discovery in cancer research is emerging with the use of nanobodies to re-engage dysfunctional p53. This vital malignant protector protein is frequently inactivated in several forms of cancer, causing https://orangebookmarks.com/story22007516/mini-antibodies-revive-tumor-suppressor-p53-the-promising-hope-for-malignant-management